Search research articles
Contact Us
Filters
Showing results (1-10 of 13) with videos related to
Page
of 2
Sort By:
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 26, 2025
Biomarkers
Agnieszka Kulczynska-Przybik, Daria Krawczuk, Renata Borawska, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 26, 2025
Biomarkers
Barbara Mroczko, Agnieszka Kulczynska-Przybik, Daria Krawczuk, et al.
International Journal of Molecular Sciences
|
September 23, 2022
Evaluation of Synaptic and Axonal Dysfunction Biomarkers in Alzheimer's Disease and Mild Cognitive Impairment Based on CSF and Bioinformatic Analysis
Maciej Dulewicz, Agnieszka Kulczyńska-Przybik, Renata Borawska, et al.
Journal of Clinical Medicine
|
October 13, 2021
Neurogranin and Neuronal Pentraxin Receptor as Synaptic Dysfunction Biomarkers in Alzheimer's Disease
Maciej Dulewicz, Agnieszka Kulczyńska-Przybik, Agnieszka Słowik, et al.
Journal of Clinical Medicine
|
July 24, 2021
Fatty Acid Binding Protein 3 (FABP3) and Apolipoprotein E4 (ApoE4) as Lipid Metabolism-Related Biomarkers of Alzheimer's Disease
Maciej Dulewicz, Agnieszka Kulczyńska-Przybik, Agnieszka Słowik, et al.
Journal of Clinical Medicine
|
November 27, 2021
The Clinical Significance of Cerebrospinal Fluid Reticulon 4 (RTN4) Levels in the Differential Diagnosis of Neurodegenerative Diseases
Agnieszka Kulczyńska-Przybik, Maciej Dulewicz, Agnieszka Słowik, et al.
Journal of Clinical Medicine
|
July 29, 2023
Potential Utility of Cerebrospinal Fluid Glycoprotein Nonmetastatic Melanoma Protein B as a Neuroinflammatory Diagnostic Biomarker in Mild Cognitive Impairment and Alzheimer's Disease
Julia Doroszkiewicz, Agnieszka Kulczyńska-Przybik, Maciej Dulewicz, et al.
Current Alzheimer Research
|
November 10, 2020
Cerebrospinal Fluid and Blood CX3CL1 as a Potential Biomarker in Early Diagnosis and Prognosis of Dementia
Agnieszka Kulczyńska-Przybik, Agnieszka Słowik, Piotr Mroczko, et al.
Journal of Alzheimer'S Disease : JAD
|
August 28, 2014
Evaluation of visinin-like protein 1 concentrations in the cerebrospinal fluid of patients with mild cognitive impairment as a dynamic biomarker of Alzheimer's disease
Barbara Mroczko, Magdalena Groblewska, Marzena Zboch, et al.
International Journal of Molecular Sciences
|
September 9, 2023
The Relationships between Cerebrospinal Fluid Glial (CXCL12, CX3CL, YKL-40) and Synaptic Biomarkers (Ng, NPTXR) in Early Alzheimer's Disease
Agnieszka Kulczyńska-Przybik, Maciej Dulewicz, Julia Doroszkiewicz, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 13) with videos related to
Sort By:
Page
of 2
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 26, 2025
Biomarkers
Agnieszka Kulczynska-Przybik, Daria Krawczuk, Renata Borawska, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 26, 2025
Biomarkers
Barbara Mroczko, Agnieszka Kulczynska-Przybik, Daria Krawczuk, et al.
International Journal of Molecular Sciences
|
September 23, 2022
Evaluation of Synaptic and Axonal Dysfunction Biomarkers in Alzheimer's Disease and Mild Cognitive Impairment Based on CSF and Bioinformatic Analysis
Maciej Dulewicz, Agnieszka Kulczyńska-Przybik, Renata Borawska, et al.
Journal of Clinical Medicine
|
October 13, 2021
Neurogranin and Neuronal Pentraxin Receptor as Synaptic Dysfunction Biomarkers in Alzheimer's Disease
Maciej Dulewicz, Agnieszka Kulczyńska-Przybik, Agnieszka Słowik, et al.
Journal of Clinical Medicine
|
July 24, 2021
Fatty Acid Binding Protein 3 (FABP3) and Apolipoprotein E4 (ApoE4) as Lipid Metabolism-Related Biomarkers of Alzheimer's Disease
Maciej Dulewicz, Agnieszka Kulczyńska-Przybik, Agnieszka Słowik, et al.
Journal of Clinical Medicine
|
November 27, 2021
The Clinical Significance of Cerebrospinal Fluid Reticulon 4 (RTN4) Levels in the Differential Diagnosis of Neurodegenerative Diseases
Agnieszka Kulczyńska-Przybik, Maciej Dulewicz, Agnieszka Słowik, et al.
Journal of Clinical Medicine
|
July 29, 2023
Potential Utility of Cerebrospinal Fluid Glycoprotein Nonmetastatic Melanoma Protein B as a Neuroinflammatory Diagnostic Biomarker in Mild Cognitive Impairment and Alzheimer's Disease
Julia Doroszkiewicz, Agnieszka Kulczyńska-Przybik, Maciej Dulewicz, et al.
Current Alzheimer Research
|
November 10, 2020
Cerebrospinal Fluid and Blood CX3CL1 as a Potential Biomarker in Early Diagnosis and Prognosis of Dementia
Agnieszka Kulczyńska-Przybik, Agnieszka Słowik, Piotr Mroczko, et al.
Journal of Alzheimer'S Disease : JAD
|
August 28, 2014
Evaluation of visinin-like protein 1 concentrations in the cerebrospinal fluid of patients with mild cognitive impairment as a dynamic biomarker of Alzheimer's disease
Barbara Mroczko, Magdalena Groblewska, Marzena Zboch, et al.
International Journal of Molecular Sciences
|
September 9, 2023
The Relationships between Cerebrospinal Fluid Glial (CXCL12, CX3CL, YKL-40) and Synaptic Biomarkers (Ng, NPTXR) in Early Alzheimer's Disease
Agnieszka Kulczyńska-Przybik, Maciej Dulewicz, Julia Doroszkiewicz, et al.
Page
of 2